Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | PAM | P19021 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | PRKCA | P17252 | 1/20 | 0.46 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.46 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.46 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4627242 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL27764263 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL9666107 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL3284598 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL29043323 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL4627513 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL17204169 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL15689282 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL15649885 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 | |
| SCHEMBL4627239 | 1.00 | LMNA (0.56) | LMNAMAPTDGKAPAMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025043460-A1 | ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS | L'OREAL (FR) | 2025-03-06 | — | — | WO | claimed |
| EP-4138770-A1 | TRANSPARENT SHAMPOO BAR AND METHOD FOR PREPARING THE SAME | Henkel AG & Co. KGaA (DE) | 2023-03-01 | — | — | EP | claimed |
| CN-115427007-A | Transparent shampoo block and preparation method thereof | 汉高股份有限及两合公司 | 2022-12-02 | — | — | CN | claimed |
| US-20220378677-A1 | TREATMENT OF TOOTH DECAY USING A CHEWING GUM COMPOSITION COMPRISING CANNABINOIDS | M. MUSTIX LTD (IL) | 2022-12-01 | — | — | US | claimed |
| US-20210379010-A1 | COMPOSITIONS COMPRISING CANNABINOIDS FOR USE IN THE TREATMENT OF BIOFILM AND CONDITIONS ASSOCIATED WITH MICROBIAL, FUNGAL, BACTERIAL INFECTIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2021-12-09 | — | — | US | claimed |
| WO-2021212404-A1 | TRANSPARENT SHAMPOO BAR AND METHOD FOR PREPARING THE SAME | HENKEL AG & CO. KGAA (DE) | 2021-10-28 | — | — | WO | claimed |
| EP-3873449-A1 | COMPOSITIONS COMPRISING CANNABINOIDS FOR USE IN THE TREATMENT OF BIOFILM AND CONDITIONS ASSOCIATED WITH MICROBIAL, FUNGAL, BACTERIAL INFECTIONS | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2021-09-08 | — | — | EP | claimed |
| WO-2021084543-A1 | TREATMENT OF TOOTH DECAY USING A CHEWING GUM COMPOSITION COMPRISING CANNABINOIDS | M. MUSTIX LTD (IL) | 2021-05-06 | — | — | WO | claimed |
| CN-109575645-B | Aluminum paste for alcohol-water type ink and preparation method thereof | 长沙族兴新材料股份有限公司 | 2020-12-29 | — | — | CN | claimed |
| EP-2331056-A1 | USE OF AN N-ACYL AMINO ACID SELECTED FROM AMONG N-PALMITOYL ALANINE, N-PALMITOYL GLYCINE, N-PALMITOYL ISOLEUCINE, AND N-COCOYL ALANINE AS AN ACTIVE AGENT CONTROLLING THE PROPORTION OF BASAL KERATINOCYTES OF THE HUMAN SKIN EPIDERMIS AND EXPRESSING THE NUCLEAR FORM OF SURVIVING, AND ANTI-AGING COSMETIC COMPOSITION COMPRISING SAME | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2011-06-15 | — | — | EP | claimed |
| WO-2010026325-A1 | USE OF AN N-ACYL AMINO ACID SELECTED FROM AMONG N-PALMITOYL ALANINE, N-PALMITOYL GLYCINE, N-PALMITOYL ISOLEUCINE, AND N-COCOYL ALANINE AS AN ACTIVE AGENT CONTROLLING THE PROPORTION OF BASAL KERATINOCYTES OF THE HUMAN SKIN EPIDERMIS AND EXPRESSING THE NUCLEAR FORM OF SURVIVING, AND ANTI-AGING COSMETIC COMPOSITION COMPRISING SAME | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2010-03-11 | — | — | WO | claimed |
| US-20260076887-A1 | PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS | PROCTER & GAMBLE (US) | 2026-03-19 | — | — | US | disclosed |
| US-20250268805-A1 | PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS | THE PROCTER & GAMBLE COMPANY | 2025-08-28 | — | — | US | disclosed |
| WO-2025043460-A1 | ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS | L'OREAL (FR) | 2025-03-06 | — | — | WO | disclosed |
| CN-115916887-B | Amphiphilic alginic acid particle group and method for producing the same | 日清纺控股株式会社 | 2024-12-03 | — | — | CN | disclosed |
| WO-1999044986-A1 | ACYLATED AMINOACIDS FOR INCREASING THE UPTAKE OF SELECTED SUBSTANCES BY ORGANISMS | LOVESGROVE RESEARCH LIMITED (GB) | 1999-09-10 | — | — | WO | disclosed |
| US-5529712-A | CONTAINING N-ACYL AMINO ACID SALT OF GLYCINE, ALANINE OR BETA-ALANINE, HIGHER FATTY ACID SALT IN SPECIFIED WEIGHT RATIO | AJINOMOTO CO., INC. (JP) | 1996-06-25 | — | — | US | disclosed |
| EP-0648833-A1 | DETERGENT COMPOSITION | Ajinomoto Co., Inc. (JP) | 1995-04-19 | — | — | EP | disclosed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | disclosed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250268805-A1 | PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS | SMURF1, CUTA, SMURF2 | LMNA 3581/4885MAPT 2822/4885DGKA 810/4885 |
| US-20260076887-A1 | PERSONAL CARE COMPOSITIONS CONTAINING TAILORED MONOLIPID-RHAMNOLIPIDS AND SULFATE-FREE SURFACTANTS | CUTA, PHOSPHO1, MGLL | LMNA 2819/4885MAPT 3145/4885DGKA 2226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.